Influence of trimetazidine combined with levocarnitine on levels of serum myeloperoxidas, soluble suppression of tumorigenicity 2 and N-terminal pro-brain natriuretic peptide in patients with acute myocardial infarction after PCI

Guo Yuehan; Li Nian; Xu Ting; Zhang Lei; Zhou Le; Xie Yidan

doi:10.3969/j.issn.1674-4055.2021.09.15

Home>Articles>Influence of trimetazidine combined with levocarnitine on levels of serum myeloperoxidas, soluble suppression of tumorigenicity 2 and N-terminal pro-brain natriuretic peptide in patients with acute myocardial infarction after PCI

DOI: 10.3969/j.issn.1674-4055.2021.09.15

Influence of trimetazidine combined with levocarnitine on levels of serum myeloperoxidas, soluble suppression of tumorigenicity 2 and N-terminal pro-brain natriuretic peptide in patients with acute myocardial infarction after PCI

Guo Yuehan

Li Nian

Xu Ting

Zhang Lei

Zhou Le

Xie Yidan

Machine-generated Keywords：

Publication Date：2021-09-28

Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)

Pages：4( 1090-1092,1095 )

Chinese Journal of Evidence-Bases Cardiovascular Medicine

ISTIC

ISSN：1674-4055

Year, Vol.(Issue)：2021,13(9)